Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
Deleu
Dirk
D
Hanssens
Yolande
Y
D019540:Area Under Curve; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use*; D013810:Therapeutic Equivalency; D014363:Tryptamines; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D007211:Indoles; D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D014662:Vasoconstrictor Agents; C115647:eletriptan; D018170:Sumatriptan